639
Views
20
CrossRef citations to date
0
Altmetric
Brief Communication

Mixed amlodipine/valsartan overdose treated by the molecular adsorbent recirculating system (MARS™)

, , &
Pages 573-577 | Received 12 Feb 2015, Accepted 07 May 2015, Published online: 26 May 2015

References

  • Koch AR, Vogelaers DP, Decruyenaere JM, Callens B, Verstraete A, Buylaert WA. Fatal intoxication with amlodipine. J Toxicol Clin Toxicol 1995; 33:253–256.
  • Smith SW, Ferguson KL, Hoffman RS, Nelson LS, Greller HA. Prolonged severe hypotension following combined amlodipine and valsartan ingestion. Clin Toxicol (Phila) 2008; 46:470–474.
  • Wittebole X, Hantson P. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clin Toxicol (Phila) 2011; 49:782–793.
  • Pichon N, Dugard A, Clavel M, Amiel JB, François B, Vignon P. Extracorporeal albumin dialysis in three cases of acute calcium channel blocker poisoning with life-threatening refractory cardiogenic shock. Ann Emerg Med 2012; 59:540–544.
  • Plumb JO, Stewart C, Eddleston M, de Beer T. Prolonged refractory hypotension following combined amlodipine and losartan ingestion responsive to metaraminol. Case Rep Med 2011; 2011:283672.
  • St-Onge M, Dubé PA, Gosselin S, Guimont C, Godwin J, Archambault PM, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila) 2014; 52:926–944.
  • French D, Smollin C, Ruan W, Wong A, Drasner K, Wu AH. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol (Phila) 2011; 49:801–809.
  • West PL, McKeown NJ, Hendrickson RG. Latrogenic lipid emulsion overdose in a case of amlodipine poisoning. Clin Toxicol (Phila) 2010; 48:393–396.
  • Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol (Phila) 2010; 48:806–812.
  • Belleflamme M, Hantson P, Gougnard T, Minon JM, Wittebole X, Laterre PF, et al. Survival despite extremely high plasma diltiazem level in a case of acute poisoning treated by the molecular-adsorbent recirculating system. Eur J Emerg Med 2012; 19:59–61.
  • Deters M, Friesecke S, Hentschel H. Fatal poisoning caused by felodipine. Abstracts of the 2010 international congress of the association of poison centres and clinical toxicologists, 11–14 may 2010, bordeaux, france. Clin Toxicol (Phila) 2010; 48:281.
  • Pichon N, François B, Chevreuil C, Gaulier JM. Albumin dialysis: a new alternative for severe diltiazem intoxication. Clin Toxicol (Phila) 2006; 44:195–196.
  • Maddi S, Yamsani MR, Seeling A, Scriba GK. Stereoselective plasma protein binding of amlodipine. Chirality 2010; 22:262–266.
  • Colussi DM, Parisot C, Rossolino ML, Brunner LA, Lefèvre GY. Protein binding in plasma of valsartan, a new angiotensin II receptor antagonist. J Clin Pharmacol 1997; 37:214–221.
  • Stopher DA, Beresford AP, Macrae PV, Humphrey MJ. The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 1988; 12:S55–S59.
  • Reiss WG, Bauer LA, Horn JR, Zierler BK, Easterling TR, Strandness DE Jr. The effects of oral nifedipine on hepatic blood flow in humans. Clin Pharmacol Ther 1991; 50:379–384.
  • Sharma A, Trane A, Yu C, Jasmin JF, Bernatchez P. Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1. Eur J Pharmacol 2011; 659:206–212.
  • Su KH, Tsai JY, Kou YR, Chiang AN, Hsiao SH, Wu YL, et al. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovasc Res 2009; 82:468–475.
  • Jang DH, Nelson LS, Hoffman RS. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med 2011; 58:565–567.
  • Jang DH, Donovan S, Nelson LS, Bania TC, Hoffman RS, Chu J. Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock. Ann Emerg Med 2015; 65:410–415.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.